Last reviewed · How we verify

NCT03024931: MrBurn

Metabolic Rate in Burns

Status unknown Last updated 13 March 2018
What this trial tests

trial testing observational study in Burns in 10 participants. Status unknown.

Timeline
1 January 2017
Primary endpoint
1 May 2019
1 December 2019

Quick facts

Lead sponsorChelsea and Westminster NHS Foundation Trust
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment10
Start date1 January 2017
Primary completion1 May 2019
Estimated completion1 December 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Chelsea and Westminster NHS Foundation Trust

Who can join

16 and older, any sex, with Burns. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Severe burn patients are some of the most challenging critically ill patients with an extreme and continuous state of physiological stress. Patients tends to stay for a long period of time in intensive care unit to treat burns as well as dealing with complications that arises from the initial burns injury. Severe burns patients are notoriously known to loose weight. The word 'catabolism' is used medically. This theory of catabolism after a trauma was hypothesised in 1942 by Professor Curthberston and based on animal models. Since this date, despite medical technological advancement, there has been no research that confirms Professor Curthberston's theory. Investigators still do not know the exact mechanism by which the body changes from conserving energy to becoming catabolic. Furthermore, it remains unclear whether this change in catabolism is necessary to heal from burns injury. This theoretical catabolism in burns patients is currently treated with nutritional supplement, use of medications including beta-blockers (suppresses heart rate and decreases blood pressure) and oxandrolone (formula which is similar to testosterone to build up muscles). There are evidences to suggest that increase in weight loss worsens the outcome in burns injury. Both overfeeding or underfeeding patients can be detrimental. In this research, the exact changes in metabolic rate will be measured in the first 72 hours of the study using a calorimetry machine. In addition to the metabolic rate, the response to the heart, liver, kidneys and hormonal levels will be measured. By looking into these dynamic changes the investigator will be able to elucidate whether there is a real increase in metabolic rate. If there is, the investigator would also be able to tell the response of different organs and whether there are any hormones that could be responsible to inflicting the metabolic changes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of observational study

Trials testing the same drug.

Other recruiting trials for Burns

Currently open trials in the same condition.

Other Chelsea and Westminster NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03024931.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing